tiprankstipranks
Universe Pharmaceuticals (UPC)
NASDAQ:UPC
US Market
Holding UPC?
Track your performance easily

Universe Pharmaceuticals (UPC) Financial Statements

80 Followers

Universe Pharmaceuticals Financial Overview

Universe Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-1.7; its P/E ratio is -0.17; Universe Pharmaceuticals is scheduled to report earnings on February 4, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Sep 22Mar 22Sep 21Mar 21
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 18.50M$ 18.86M$ 28.58M$ 21.80M$ 36.00M
Total Assets$ 53.29M$ 59.54M$ 71.37M$ 70.14M$ 67.27M
Total Debt$ 5.48M$ 3.94M$ 4.41M$ 4.33M$ 2.75M
Net Debt$ -13.02M$ -14.92M$ -24.17M$ -17.47M$ -33.25M
Total Liabilities$ 13.75M$ 13.10M$ 10.21M$ 11.21M$ 16.58M
Stockholders Equity$ 39.53M$ 46.44M$ 61.16M$ 58.93M$ 50.69M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in USD

Universe Pharmaceuticals Earnings and Revenue History

Universe Pharmaceuticals Debt to Assets

Universe Pharmaceuticals Cash Flow

Universe Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis